EUR 61,92
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 60,75
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: Acceptable. SHIPS FAST. RESCUED + REPAIRED. Features a small coffee mishap, plus a reinforced binding, secured cover, and light annotations or highlighting-a durable, fully readable working copy brought back to life at a great value by our Book Sustainability Project. No access codes or CDs.
EUR 69,74
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 69,15
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 87,81
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 270.
Lingua: Inglese
Editore: Elsevier Science Health Science, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Da: Revaluation Books, Exeter, Regno Unito
EUR 84,57
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st edition. 255 pages. 9.00x7.50x0.75 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 89,48
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st pap/psc edition. 246 pages. 8.00x5.00x0.65 inches. In Stock.
Condizione: New. pp. 270.
EUR 100,76
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 270.
Lingua: Inglese
Editore: Elsevier - Health Sciences Division, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 98,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
EUR 70,66
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic. Part Two is structured by common and uncommon toxicities that af.
Lingua: Inglese
Editore: Springer Publishing Company Mär 2019, 2019
ISBN 10: 0826172148 ISBN 13: 9780826172143
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 95,13
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic. Part Two is structured by common and uncommon toxicities that affect major organ sites throughout the body.
EUR 142,09
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 83,90
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Elsevier Health Sciences Aug 2018, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 90,99
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource. 270 pp. Englisch.
Lingua: Inglese
Editore: Elsevier Health Science|Elsevier, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Da: moluna, Greven, Germania
EUR 91,88
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-dat.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 102,89
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource.